IRIS
MONTAGNANI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.345
NA - Nord America 17.449
AS - Asia 9.265
SA - Sud America 1.656
AF - Africa 592
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 19
Totale 50.373
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.008
IT - Italia 6.404
RU - Federazione Russa 4.188
GB - Regno Unito 2.978
SG - Singapore 2.654
CN - Cina 2.612
IE - Irlanda 2.077
BR - Brasile 1.355
DE - Germania 1.337
VN - Vietnam 1.231
SE - Svezia 917
FR - Francia 904
HK - Hong Kong 821
FI - Finlandia 737
UA - Ucraina 655
KR - Corea 379
IN - India 373
NL - Olanda 354
ZA - Sudafrica 323
BD - Bangladesh 311
CA - Canada 260
ES - Italia 184
PL - Polonia 117
IQ - Iraq 110
TR - Turchia 101
AR - Argentina 95
MX - Messico 95
AT - Austria 94
JP - Giappone 77
BE - Belgio 70
IR - Iran 70
PK - Pakistan 64
ID - Indonesia 60
CZ - Repubblica Ceca 57
CI - Costa d'Avorio 48
NG - Nigeria 48
UZ - Uzbekistan 47
CH - Svizzera 45
PH - Filippine 45
EC - Ecuador 43
CO - Colombia 41
SA - Arabia Saudita 38
AU - Australia 36
AE - Emirati Arabi Uniti 34
MY - Malesia 34
VE - Venezuela 33
KE - Kenya 32
EG - Egitto 31
LT - Lituania 27
CL - Cile 25
JO - Giordania 25
MA - Marocco 23
PE - Perù 23
AZ - Azerbaigian 21
PT - Portogallo 21
IL - Israele 20
RO - Romania 19
JM - Giamaica 18
PY - Paraguay 18
AL - Albania 17
BG - Bulgaria 17
DZ - Algeria 17
NP - Nepal 17
TN - Tunisia 17
EU - Europa 16
CR - Costa Rica 14
ET - Etiopia 14
LV - Lettonia 14
DK - Danimarca 13
UG - Uganda 13
OM - Oman 12
BO - Bolivia 11
EE - Estonia 11
HU - Ungheria 11
KZ - Kazakistan 11
SK - Slovacchia (Repubblica Slovacca) 11
TT - Trinidad e Tobago 11
GR - Grecia 10
PA - Panama 10
PS - Palestinian Territory 10
UY - Uruguay 10
HR - Croazia 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
TW - Taiwan 8
AM - Armenia 7
BY - Bielorussia 7
GE - Georgia 7
LB - Libano 7
RS - Serbia 7
SV - El Salvador 7
BH - Bahrain 6
CY - Cipro 6
LK - Sri Lanka 6
LU - Lussemburgo 6
MD - Moldavia 6
SN - Senegal 6
TH - Thailandia 6
AO - Angola 5
DO - Repubblica Dominicana 5
Totale 50.280
Salva come PNG Salva come JPEG
Città #
Dallas 4.129
Southend 2.391
Dublin 2.028
Singapore 1.568
Moscow 1.202
Ashburn 1.153
Milan 1.145
Chandler 1.114
San Jose 996
Santa Clara 880
Hong Kong 761
Beijing 687
Munich 666
Fairfield 558
Hefei 517
Siena 514
Jacksonville 509
Rome 504
Helsinki 500
Council Bluffs 445
Los Angeles 439
New York 381
Seoul 368
Ann Arbor 365
Ho Chi Minh City 344
Princeton 303
Woodbridge 282
Florence 280
Johannesburg 272
Hanoi 262
Wilmington 242
Lauterbourg 238
Seattle 233
Cambridge 192
Houston 188
The Dalles 188
Nanjing 185
Dong Ket 182
São Paulo 138
Buffalo 136
Menlo Park 136
Boardman 126
Turin 118
Shanghai 108
Frankfurt am Main 107
Orem 105
Naples 100
Málaga 93
Toronto 92
Turku 88
Chennai 87
Chicago 86
Nuremberg 84
Bologna 82
San Mateo 82
London 81
Düsseldorf 79
Warsaw 74
Montreal 71
Tokyo 67
Brescia 65
Bengaluru 63
Nanchang 63
Brussels 62
Dearborn 60
Figino 56
Genoa 56
Denver 55
Redondo Beach 54
Lancaster 53
Brooklyn 52
Stockholm 52
Vienna 52
Atlanta 50
Da Nang 50
Portsmouth 50
Fremont 49
Phoenix 49
Abidjan 48
San Diego 46
Guangzhou 45
Baghdad 44
Amsterdam 43
Catania 43
Shenyang 43
Haiphong 42
Lappeenranta 42
Palermo 42
Rio de Janeiro 42
Tashkent 42
Washington 42
San Francisco 41
Poplar 38
Bari 37
Paris 37
Changsha 36
Abuja 34
Mexico City 34
Redwood City 34
Perugia 32
Totale 31.229
Salva come PNG Salva come JPEG
Nome #
Utilizzo di dalbavancina nella terapia delle infezioni osteoarticolari 1.398
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 638
A first update on mapping the human genetic architecture of COVID-19 589
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 587
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art 580
MENINGITE VIRALE DA HHV7. DESCRIZIONE DI UN CASO IN ADULTO IMMUNOCOMPETENTE 577
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 570
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 569
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 523
Crisi comiziale generalizzata in giovane paziente proveniente dal Togo 471
Genetic mechanisms of critical illness in COVID-19 434
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 426
Analisi di clonalità di isolati di Streptococcus pyogenes resistenti ai macrolidi: fluttuazioni della dinamica di popolazione negli ultimi 8 anni 408
An explainable model of host genetic interactions linked to COVID-19 severity 375
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 372
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 371
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 368
Pathogen-sugar interactions revealed by universal saturation transfer analysis 363
Analisi della sensibilità a penicillina in isolati comunitari di Streptococcus pneumoniae: implicazioni cliniche in relazione alle concentrazioni minime inibenti 363
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 328
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 323
Analisi preliminare sull’impatto clinico-organizzativo della gestione delle ABSSSI: focus sui criteri di dimissione precoce 322
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 320
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 317
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 308
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 308
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 308
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 304
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 302
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 301
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 297
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 297
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 290
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 290
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes 290
Case Report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy 287
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 286
Strategie di vaccinazione anti-pneumococcica nel paziente adulto HIV-positivo: confronto fra vaccino coniugato 13-valente e vaccino polisaccaridico 23-valente 281
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 279
Evolution of macrolide resistance in streptococcus pyogenes over 14 years in an area of central Italy 278
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region 277
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 276
First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host 275
Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine 274
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 270
Pediatric spinal epidural abscess in an immunocompetent host without risk factors: Case report and review of the literature 266
Valutazione microbiologica del rischio infettivo nella chirurgia della cataratta 262
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 262
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 260
Prognostic bioindicators in severe COVID-19 patients 257
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 257
ERADICAZIONE DI INFEZIONE DA HCV DOPO TRATTAMENTO DI 8 SETTIMANE CON GRAZOPREVIR/ELBASVIR: CASE REPORT 251
Serial KL-6 measurements in COVID-19 patients 250
Approccio perinatale al neonato che ha presentato malessere fetale 249
Clinical and microbiological features of acute bacterialconjunctivitis at the primary eye care unit in a hospital of centralItaly 249
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 247
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. 246
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 243
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 242
Clindamycin-resistant Streptococcus pneumoniae 241
Antimicrobial Susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: Surveillance from 1993 to 2004 in Central Italy 241
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 241
Un caso di “insolita” spondilodiscite da Staphylococcus capitis 240
Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients 236
Clinical and microbiological features of acute bacterial conjunctivitis at the primary eye care unit in a hospital of central Italy 236
Serotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategies 235
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 235
Risposta immunitaria a lungo termine dopo vaccinazione antipneumococcica con vaccino coniugato 13-valente o vaccino polisaccaridico 23-valente in adulti HIV positivi 234
Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 234
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 233
Descrizione di un'epidemia da Enterobacteriaceae multiresistenti in un'unità di terapia intensiva neonatale 232
Resistenza ai beta-lattamici in Streptococcus pneumoniae: 10 anni di sorveglianza nell’area senese 231
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 230
Diagnosi di sarcoidosi in nuova diagnosi di HIV 230
Discovery of new Mycoplasma pneumoniae antigens by use of a whole genome lambda display library 229
Meningite postchirurgica e infezione di cute e tessuti molli da Acinetobacter baumannii extensively drug resistant (XDR) 227
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 227
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 222
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 221
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 221
Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006 220
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 218
Casistica di malattia reumatica e glomerulonefrite poststreptococcica: patologie passate o riemergenti? 218
Sierotipizzazione di isolati invasivi di Streptococcus pneumoniae: utilità della PCR multiplex nella sorveglianza epidemiologica 218
Ridotta sensibilità a penicillina in Streptococcus pneumoniae: analisi microbiologica di ceppi di recente isolamento 217
A complex outbreak of multiresistant Enterobacteriaceae producing the acquired AmpC-type beta-lactamase FOX-7 in a neonatal intensive care unit setting 216
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 216
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 216
PATOGENI COLONIZZANTI IL NASOFARINGE DI SOGGETTI HIV POSITIVI E HIV NEGATIVI 215
MIASI CAVITARIA A LOCALIZZAZIONE NASALE DA OESTRUS OVIS: UN CASO CLINICO 214
Prevalence of M75 Streptococcus Pyogenes strains harboring slaa gene in patients affected by pediatric obstructive sleep apnea syndrome in Central Italy 214
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 213
WES profiling of COVID-19 213
Un raro caso di osteomielite da Moraxella osloensis e Staphylococcus capitis in giovane paziente immunocompetente 213
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia 212
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 211
Evoluzione ed efficace controllo di un vasto focolaio epidemico nosocomiale da Klebsiella pneumoniae produttrice di carbapenemasi in un’area Neurochirurgica: lezioni apprese. 210
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 210
Whole-genome sequencing reveals host factors underlying critical COVID-19 208
Totale 30.479
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.498 185 264 142 176 152 89 113 124 130 206 308 609
2022/20234.308 250 458 509 519 364 711 228 375 351 171 208 164
2023/20244.411 141 114 404 291 213 977 1.262 171 71 205 235 327
2024/20259.396 392 415 948 436 1.039 703 774 673 901 443 856 1.816
2025/202622.344 1.383 2.745 3.376 2.742 3.910 780 2.356 710 816 1.223 845 1.458
2026/2027404 404 0 0 0 0 0 0 0 0 0 0 0
Totale 51.159